Quantcast

Latest Microbicides for sexually transmitted diseases Stories

2009-02-24 11:02:00

New support will accelerate development of new tools to help women protect themselves from HIV SILVER SPRING, Md., Feb. 24 /PRNewswire-FirstCall/ -- The International Partnership for Microbicides (IPM) announced today that it has received a total of US $130 million in grants from the UK Department for International Development (DFID) and the Bill & Melinda Gates Foundation, reinforcing the global commitment to address the HIV epidemic in women. Globally, 7,000 new cases of HIV...

2009-02-10 23:52:16

AIDS researchers meeting in Montreal say anitretroviral drugs given by vaginal gel may be effective at preventing HIV infection. The Washington Post reported Tuesday that two experiments in monkeys showed oral or vaginal treatment of tenofovir, or a combination drug that also contained emtricitabine, was highly effective in blocking HIV infection. A third study, which involved 3,100 women in the United States and Africa, found a microbicide vaginal gel called PRO 2000/5 prevented HIV from...

2009-02-09 07:42:00

Dr. Zeda Rosenberg, CEO of the International Partnership for Microbicides, issued the following statement on the results of the Phase II/IIb safety and effectiveness study of BufferGel and PRO2000 (0.5 percent concentration): SILVER SPRING, Md., Feb. 9 /PRNewswire/ -- The Microbicide Trials Network, a worldwide collaborative group funded by the US National Institutes of Health, has released final results from its Phase II/IIb safety and effectiveness study of two microbicides, BufferGel and...

2009-02-09 06:28:00

Results of NIH-sponsored Clinical Trial to be Presented at Retrovirus Conference LEXINGTON, Mass., Feb. 9 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today that a National Institutes of Health (NIH)-sponsored clinical study found that participating women who received PRO 2000, the Company's candidate vaginal microbicide for HIV prevention, had an approximately 30% lower risk of acquiring HIV infection than women who received a placebo or no vaginal...

2009-01-02 12:27:18

Carraguard microbicidal gel does not protect women from HIV infection, new information reveals. About 33.2 million people around the world are living with HIV. Women and girls are most often the victims, accounting for 61 percent of infections. In addition in people ages 15 to 24 years, women account for 90 percent of new cases, making female initiated HIV prevention options like microbicides a critical need. A trial in South Africa involving 6,202 sexually active women without HIV tested...

2008-08-22 09:01:11

LEXINGTON, Mass., Aug. 22 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. announced today the completion of enrollment in Protocol MDP 301, a Phase III clinical trial of PRO 2000, the Company's candidate vaginal microbicide for the prevention of HIV and other sexually transmitted infections. The trial is sponsored by the United Kingdom's Medical Research Council (MRC) and conducted by the Microbicides Development Programme (MDP), an international partnership of researchers...

2008-07-29 09:01:15

FREDERICK, Md., July 29 /PRNewswire/ -- ImQuest BioSciences announced today the successful acquisition of funding from the National Institute of Allergy and Infectious Disease (NIAID/NIH) to support the development of pyrimidinedione inhibitors as topical microbicides to prevent the sexual transmission of HIV. The two year Small Business Innovative Research (SBIR) grant provides funding for the continued development of the dual-acting pyrimidinedione molecules which effectively inhibit two...

343d871ec7fd4dce554c9b2d572078e0
2008-07-08 13:37:12

Gels that have been developed to protect women from the AIDS virus may be just as likely to protect men from catching the disease as well, researchers said on Monday. That prediction would rely on the event of such gels and creams being perfected to be effective for men. Sally Blower of the University of California, Los Angeles, and David Wilson of the University of New South Wales in Sydney, Australia said women who use gels of microbicides could end up with fewer treatment options if they...

1a4f455aece78da954e32efc1a54de641
2008-02-18 14:30:00

Researchers announced their disappointment upon finding that an anti-AIDS vaginal gel failed to stop HIV infection in their study of 6,000 South African women. The gel was the first of its kind to make it through late-stage testing.Over 9,000 women volunteered for the study which was conducted from March 2004 through March 2007 in Gugulethu, Isipingo and Soshanguve. About 27 percent of the volunteers were found to already be infected with HIV and were disqualified from testing. The women were...

2006-08-14 04:30:00

By Maggie Fox, Health and Science Correspondent TORONTO -- A cream, gel or pill that women can use to protect themselves from the AIDS virus is key to stopping the AIDS pandemic, Microsoft founder Bill Gates, who has given hundreds of millions of dollars to HIV programs, said on Sunday. Gates said he would step up funding for prevention research but said governments and other donors needed to do so, also. "We want to call on everyone here and around the world to help speed up what we hope...


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related